|
Etravirine (TMC 125)
Etravirine (TMC-125) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), designed to be active against HIV with mutations t...
More>>
|
|
|
HMN 214 (IVX 214)
HMN-214 (IVX-214) is an oral and potent inhibitor to Polo-like kinase (Plk)1 with IC50 of 118 nM. HMN-214 is an oral prodrug that is rapidly converted...
More>>
|
|
|
LY 2603618 (IC 83)
LY2603618 (IC83) is a highly selective Chk 1 inhibitor with potential antitumor activity. LY-2603618 (IC-83) binds to and inhibits the activity of chk...
More>>
|
|
|
|
BS 181
BS-181 is a highly selective cyclin-dependent kinase (CDK) inhibitor of CDK7 activity with IC50 of 21 nM. CDK7, which also regulates transcription as ...
More>>
|
|
|
CGP 60474
CGP60474 is a potent inhibitor of cyclin-dependent kinase (CDK). [1]
Reference:
[1] J Med. Chem. 2005, 48, 4536-4546.
Chemi...
More>>
|
|
|
PHA 793887
PHA-793887 is a novel and potent inhibitor of CDK2, CDK5 and CDK7 with IC50 of 8 nM, 5 nM and 10 nM, respectively. PHA793887 was also effective in viv...
More>>
|
|
|
Dinaciclib (SCH 727965)
Dinaciclib (SCH727965) is a novel and potent cyclin-dependent kinase inhibitor for CDK2, CDK5, CDK1, and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, ...
More>>
|
|
|
PHA 848125
PHA-848125 is a potent, ATP-competitive cyclin A/CDK2 inhibitor with an IC50 of 45 nM. PHA848125 potently inhibits cyclin-dependent kinase 2 (CDK2) an...
More>>
|
|
|
R 547
R547 is a novel, selective inhibitor of cell cycle and transcriptional cyclin dependent kinases (CDKs) (Ki = 1, 3, and 1 nM for CDK1, CDK2, and CDK4, ...
More>>
|
|
|
AZD 5438
AZD5438 is a potent inhibitor of cyclin-dependent kinase (cdk) 1, 2, and 9 with IC50 of 16 nM, 6 nM, and 20 nM, respectively. AZD-5438 exhibits antipr...
More>>
|
|
|
SNS 032 (BMS 387032)
SNS-032 (BMS387032) is a novel, potent and selective CDK inhibitor of CDK2, CDK7 and CDK9 with IC50 of 38 nM, 62 nM and 4 nM, respectively. CDK inhibi...
More>>
|
|
|
Flavopiridol (HMR 1275, L 868275)
Flavopiridol (Alvocidib, HMR-1275, L-868275) is a pan-CDK inhibitor targeting CDK1, CDK2, CDK4, CDK5, CDK6, and CDK9 with IC50 of 30 nM, 170 nM, 100 n...
More>>
|
|
|
ABT 751 (E7010)
ABT-751 (E7010) is a orally bioavailable tubulin-binding and antimitotic sulfonamide which binds to the colchicine site on ß-tubulin and inhibit...
More>>
|
|
|
Kenpaullone
Kenpaullone is an ATP-competitive inhibitor of several CDKs (cyclin-dependent kinases) as well as GSK-3 (glycogen synthase kinase 3). It has been show...
More>>
|
|
|
CYT 997
CYT997 is a novel anti-cancer vascular disrupting agent (VDA). In vitro, CYT-997 is shown to potently inhibit the proliferation of vascular endothelia...
More>>
|
|